{
    "title": "Novartis loses long-running battle in Indian courts to patent its cancer drug Glivec",
    "url": "https://www.dailymail.co.uk/money/markets/article-2302423/Novartis-loses-Indian-battle-cancer-drug-Glivec.html",
    "date": "2013-04-01",
    "keywords": [
        "drug",
        "india",
        "novartis",
        "glivec",
        "treatment",
        "battle",
        "cancer",
        "blow",
        "victory",
        "health",
        "ruling",
        "patent",
        "appeal",
        "city",
        "finance",
        "reporter",
        "gmt",
        "april",
        "view",
        "countrys",
        "industry",
        "company",
        "cent",
        "worth",
        "setback",
        "progress",
        "shahani",
        "director",
        "limitedthe",
        "group",
        "staff",
        "version",
        "basis",
        "court",
        "pharma",
        "foundation",
        "stone",
        "multibillionpound",
        "protection",
        "world",
        "access",
        "storm",
        "pay",
        "switzerland",
        "exit",
        "agreement",
        "boss",
        "daniel",
        "vasella",
        "goodbye",
        "payment"
    ],
    "category": [
        "money",
        "markets"
    ]
}